Breakthrough Antibacterial Going from Bench to Bedside
Gepotidacin is the tip of the spear in a new class of antibacterials.Read More
Latest in Infectious Diseases
Will Rotavirus Vaccines Evolve?
Vaccine development may evolve with breakthrough laboratory techniques.
Emerging Culprit in GI Disturbance During Pregnancy
Listeria is being traced to a much wider range of foods.
Virus Researcher James Crowe Turns to RSV Drug Development
A pioneer in the fight against viral disease during the pandemic turns his attention to the spike in respiratory syncytial virus.
Partners in Care
Medical expertise infused with integrated technology allows Vanderbilt Health specialists to build partnerships and elevate care in complex and specialized cases. Browse our referral directory or log into our online portal for referring providers.Make a Referral
Researchers Examine Risks of Necrotizing Enterocolitis in Premature Infants
In-depth characterization of necrotizing enterocolitis yields new data on the burden of sepsis and how to predict those at highest risk.
Medication for Smoking Reduced Heavy Drinking in HIV Patients
Study in population living with HIV reflects findings in other groups and makes a strong case for cytisine approval in the U.S.
New Diagnostic Prediction Model for Pediatric MIS-C
Study offers diagnostic guidance for rare multisystem inflammatory syndrome in children.
Clinic Takes Broad View in Grappling with Long COVID
With questions still outnumbering answers, physicians in a long COVID clinic help patients caught in the pandemic kaleidoscope.
Antibodies to Coagulation Factors Studied in COVID Vaccine Recipients
Innate or acquired coagulation inhibitors may heighten hemorrhagic risk, but national data suggest this is rare.
Testing Equipment Devised to Relieve Pandemic Shortage
The PytuTester developed by critical care physicians and bioengineers enables testing of DIY ventilators in low-resource countries.